Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
COVID-19
FDA grants full approval for antiviral pill to treat mild-to-moderate COVID-19 in adults
Paxlovid is the fourth drug — and first antiviral pill — approved by the FDA to treat COVID-19 in adults.
May 25, 2023
NIH-backed project develops scoring system for identifying long-COVID patients
While multiple earlier studies have assessed the effects of long COVID, previous efforts largely had retrospective designs, relied on electronic health record entries, and lacked an uninfected comparison group.
May 25, 2023
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms
An analysis, details of which were presented Tuesday at the ATS 2023 International Conference in Washington, DC, reviewed data from 63,454 patients who were treated in a University of California medical center for COVID-19.
May 23, 2023
Antibody titer levels associated with protection against Omicron: Study
Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.
May 23, 2023
Masking and air cleaners reduced COVID-19 in two Swiss schools: Study
Face masks and portable air cleaners effectively reduced the spread of SARS-CoV-2, the virus that causes COVID-19, in two Swiss schools.
May 18, 2023
Masking should continue in healthcare settings, some experts say
Masking in healthcare settings should continue in order to optimize patient safety, recommend infectious disease experts in a commentary.
May 16, 2023
LumiraDx Q1 revenues drop 82% as its transition from non-COVID tests takes shape
In April, the company had announced a cost restructuring program involving a reduction of its global workforce by approximately 40%. It now expects to see the full impact of the restructuring activities during the third quarter.
May 16, 2023
A closer look at long COVID symptoms
Intensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.
May 10, 2023
FDA grants de novo request enabling the marketing of QuidelOrtho SARS-CoV-2 antibody tests
The tests are intended for prescription use only for the qualitative detection of IgG antibodies to SARS-CoV-2 to aid in identifying patients who have an adaptive immune response to SARS-CoV-2 from either a recent or prior infection.
May 10, 2023
Siemens Healthineers Q2 diagnostics revenues drop 39% on decline in rapid antigen test sales
The firm is seeing a return to low- to mid-single digital revenue growth as swings in demand from COVID-19 testing to routine testing normalize, Sharon Bracken, its president of diagnostics, said in an interview.
May 10, 2023
Quest Diagnostics outlines changes to IVD landscape with end in sight for U.S. public health emergency
Some retail testing -- at pharmacies, for example -- may not be available and patient-initiated testing may not be covered, Quest said.
May 8, 2023
Page 1 of 32
Next Page
